USCOM LTD.: catálogo e lista de produtos USCOM LTD. no europages. Hungria, 1-3.

Categoria

• Bens >> Suprimentos Médicos >> Equipamento médico >> Équipement médical de diagnostic
• Bens >> Suprimentos Médicos >> Equipamento médico >> Équipement chirurgical
• Bens >> Suprimentos Médicos >> Equipamento médico >> Équipement médical de laboratoire

Descrição

• Disponível em:
• English
• Português

Product Description:
The EarlyTect Colon Cancer Test is a highly reliable and clinically approved screening tool for the detection of colorectal cancer. It has been meticulously tested and approved by the Korea Ministry of Food and Drug Safety, with clinical trials conducted at renowned medical facilities such as Yonsei Medical Center, Severance Hospital, and Severance Check-up Center.

This qualitative real-time PCR test utilizes fecal DNA to accurately diagnose colorectal cancer. By measuring methylated Syndecan-2, a biomarker closely associated with precancerous lesions of CRC, the test demonstrates an impressive 90% sensitivity and specificity. It is specifically designed for asymptomatic individuals aged 30 to 80, who are suitable candidates for colorectal cancer screening.

It is important to note that while the EarlyTect Colon Cancer Test can indicate the presence of CRC or its precancerous lesions, it is not intended to provide a definitive confirmation of colorectal cancer. Therefore, if a subject tests positive, further medical evaluation is highly recommended.

Product Standard:
- Cancer Type: Colorectal Cancer
- Subject: Asymptomatic individuals suitable for colorectal cancer screening
- Biomarker: SDC2 methylation

The pricing and transaction conditions for the EarlyTect Colon Cancer Test are negotiable. We encourage you to request a quote in order to proceed with the transaction.